Gw Pharma ADR (GWPH) 82.70 $GWPH Zimmer Biomet's LDR

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2016 at 1:01 PM

Gw Pharma ADR (GWPH) 82.70 $GWPH

Zimmer Biomet's LDR Buyout On Track, Dental Still a Pain
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:45AM CDT
On Sep 2, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
ZBH: 129.06 (+0.71), GWPH: 82.70 (+0.42), QDEL: 21.61 (-0.13), NUVA: 66.08 (+0.02)

GNC Holdings Hit by Dismal Q2 Results, Competition Rife
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:12AM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
GWPH: 82.70 (+0.42), GNC: 20.79 (-0.02), QDEL: 21.61 (-0.13), LNTH: 9.55 (+0.05)

Medtronic Posts Positive Long-term Data for Micra Pacemaker
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:00AM CDT
Medtronic's (MDT) Micra TPS also successfully reduced the risk of patient hospitalization by 47% and risk of system revisions by 82%
MDT: 87.39 (+0.41), GWPH: 82.70 (+0.42), QDEL: 21.61 (-0.13), LNTH: 9.55 (+0.05)

Boston Scientific's Innovation & Emerging Market Raise Hope
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:08AM CDT
On Aug 31, 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX).
BSX: 24.18 (-0.15), GWPH: 82.70 (+0.42), QDEL: 21.61 (-0.13), LNTH: 9.55 (+0.05)

NuVasive: Strong Q2 Results, Overseas Holds Solid Prospect
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:13AM CDT
NuVasive (NUVA) posted strong results in the second quarter of 2016, with both earnings and revenues squarely beating the Zacks Consensus Estimate
GWPH: 82.70 (+0.42), QDEL: 21.61 (-0.13), LNTH: 9.55 (+0.05), NUVA: 66.08 (+0.02)

Phibro Animal Health (PAHC) Q4 Earnings Top, Decline Y/Y
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 6:51AM CDT
Phibro's (PAHC) fiscal fourth-quarter bottom line comfortably exceeding the Zacks Consensus Estimate, while its revenues expanded in low-single-digit on a year-over-year basis.
GWPH: 82.70 (+0.42), PAHC: 25.73 (+0.14), QDEL: 21.61 (-0.13), NUVA: 66.08 (+0.02)

Medtronic on Track with Covidien Synergy, Buys HeartWare
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:02AM CDT
On Aug 26, 2016, we issued an updated research report on Medtronic plc (MDT).
MDT: 87.39 (+0.41), GWPH: 82.70 (+0.42), QDEL: 21.61 (-0.13), NUVA: 66.08 (+0.02)

Hill-Rom (HRC) Hits New 52-Week High on Solid Q3 Results
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:08AM CDT
Shares of Hill-Rom (HRC) rallied to a new 52-week high of $59.45 on Aug 26.
GWPH: 82.70 (+0.42), QDEL: 21.61 (-0.13), NUVA: 66.08 (+0.02), HRC: 59.74 (+0.49)

Medtronic (MDT) Beats Q1 Earnings, Revenues Closely In-Line
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 4:29PM CDT
Medtronic plc (MDT)'s reported financial results for first-quarter fiscal 2017. Adjusted earnings per share (EPS) in the reported quarter came in at $1.03, 2 cents ahead of the Zacks Consensus Estimate.
MDT: 87.39 (+0.41), GWPH: 82.70 (+0.42), QDEL: 21.61 (-0.13), NUVA: 66.08 (+0.02)

TG Therapeutics (TGTX) Catches Eye: Stock Jumps 9.2%
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 7:00AM CDT
TG Therapeutics, Inc. (TGTX) was a big mover last session, as the company saw its shares rise over 9% on the day.
GWPH: 82.70 (+0.42), TGTX: 6.53 (+0.02)

Will GW Pharmaceuticals (GWPH) Crush Estimates at Its Next Earnings Report?
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:00AM CDT
GW Pharmaceuticals has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
GWPH: 82.70 (+0.42)

Medtronic's HeartWare Takeover Complete for $1.1 Billion
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 4:54AM CDT
With HeartWare in its kitty, Medtronic (MDT) will now gracefully lead the global VAD market for heart failure patients.
MDT: 87.39 (+0.41), GWPH: 82.70 (+0.42), QDEL: 21.61 (-0.13), HTWR: 58.20 (+0.22), NUVA: 66.08 (+0.02)

Phibro Animal Health: Currency & Competition Woes Persist
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 3:33PM CDT
Phibro (PAHC) faces competition from generic alternatives of some of its products that may weigh on its future financial health and operational performance.
GWPH: 82.70 (+0.42), PAHC: 25.73 (+0.14), BAX: 46.23 (+0.05), QDEL: 21.61 (-0.13)

The Growth of the Legal and Medical Marijuana Markets
PR Newswire - Tue Aug 23, 8:57AM CDT
The legal marijuana market in the United States is projected to grow substantially in 2016. A recent report by New Frontier and ArcView Market Research projected the marijuana market in the United States to grow to $7.1 billion in 2016, which represents a 26% growth comparing to 2015. Veritas Pharma Inc. (OTC: VRTHF), Cara Therapeutics Inc (NASDAQ: CARA), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE), Terra Tech Corp. (TRTC), GW Pharmaceuticals PLC (NASDAQ: GWPH)
CARA: 5.41 (+0.03), GWPH: 82.70 (+0.42), ZYNE: 8.40 (-0.17)

Illumina Rallies on Rumors of Takeover by Thermo Fisher
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:42AM CDT
Reportedly, Thermo Fisher (TMO) has made an all-stock offer of $30 billion to acquire Illumina (ILMN), which currently has a market cap of over $25 billion.
GWPH: 82.70 (+0.42), TMO: 150.82 (-0.13), QDEL: 21.61 (-0.13), ILMN: 168.40 (-0.16)

Cardiovascular Systems (CSII) Catches Eye: Stock Up 5.6%
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 7:40AM CDT
Cardiovascular Systems Inc. (CSII) saw its shares almost 6% in the last trading session.
CSII: 24.46 (+0.01), GWPH: 82.70 (+0.42)

Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 4:32PM CDT
Insys Therapeutics, Inc. (INSY) announced that it has enrolled the first patient in a phase II trial on its pharmaceutical cannabidiol (CBD) product candidate.
INSY: 14.59 (+0.23), GWPH: 82.70 (+0.42), CORT: 5.32 (-0.03), PCRX: 39.32 (-1.05)

Bruker's Q2 Results Disappoint, Product Launches Continue
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:14AM CDT
On Aug 12, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
GWPH: 82.70 (+0.42), QDEL: 21.61 (-0.13), BRKR: 22.34 (-0.10), NUVA: 66.08 (+0.02)

Phibro (PAHC) Focuses on Growth Amid Pricing Pressure
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 9:30AM CDT
On Aug 16, 2016, we issued an updated research report on Phibro Animal Health Corporation (PAHC).
GWPH: 82.70 (+0.42), PAHC: 25.73 (+0.14), QDEL: 21.61 (-0.13), NUVA: 66.08 (+0.02)

Zimmer Biomet Acquires CD Diagnostics, Targets PJI Market
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 9:27AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) announced the buyout of CD Diagnostics, an immunoassays and biomarker testing developer.
ZBH: 129.06 (+0.71), GWPH: 82.70 (+0.42), QDEL: 21.61 (-0.13), NUVA: 66.08 (+0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Chef André Chiang Reimagines A Joy's Autumn Menu

The Culinary World of Chef André Chiang There's a brand-new aroma wafting through Taiwan's dining scene, and it's got Chef André Chiang's signature all over it. Partnering with A Joy, a high-end buffet restaurant, this all-star chef is giving us something worth the chatter: an autumn menu that's as much about memories as it is about taste. We're looking at flavors that...

Thermoplastic Polyimide: A $0.86 Billion Market by 2032

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

WaFd and EverBank $3.9B Deal Spurs Big Bank Shift

Remember the good old days when banking was just about collecting interest? Now it's all about combining forces to bolster strength, and that's just what we're seeing with WaFd, Inc. (NASDAQ: WAFD) and EverBank Financial Corp flipping the script and shaking hands on a $3.9 billion reverse merger. Strategic Vision: A New Chapter They're calling it a 'strategic...

Early Orders Key for Custom Kids' Gifts This Season

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Indiana Fire Safety: The Importance of Regular Inspections

Everybody thinks of fire extinguishers as those red cans hanging quietly on walls, but there's more to them than meets the eye. In Central Indiana, these devices are a literal lifeline, and neglecting their upkeep is playing with fire—literally. What Makes Monthly Checks a Big Deal? Fire extinguishers aren't just there for decoration. They're critical safety gear. This...

Jixingfeng Advances Smart Manufacturing for Socks Market

Socks Evolve: From Feet Covers to Tech Gear Once upon a time, socks were merely foot covers, destined to vanish beneath pants and shoes. But not anymore. In the bustling halls of the sock world, Jixingfeng built up a robust repertoire of producing high-performance hosiery for a modern market that demands more than just warmth. They’ve turned socks into a tech-infused...

Ping An Climbs Sustainability Ladder, Scores A+ Rating

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

CME Group Smashes FX Open Interest Record Again

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

CalExitNow Fights Federal Interference in CA Elections

California's Election Integrity: A Ticking Time Bomb Strap in for a bumpy ride, folks—California might soon find its electoral process caught in a Washington whirlwind. CalExitNow, the group advocating for California's independence, is sounding alarms about looming federal interventions that could shake the state's democratic foundations. The Federal Storm Rolling In...